4//SEC Filing
Ullem Scott B. 4
Accession 0001225208-25-009797
CIK 0001099800other
Filed
Dec 8, 7:00 PM ET
Accepted
Dec 9, 5:01 PM ET
Size
9.6 KB
Accession
0001225208-25-009797
Insider Transaction Report
Form 4
Ullem Scott B.
CVP, CFO
Transactions
- Exercise/Conversion
Common Stock
2025-12-09$59.26/sh+7,700$456,277→ 47,598 total - Sale
Common Stock
2025-12-09$84.47/sh−7,700$650,412→ 39,898 total - Exercise/Conversion
Employee Stock Option (Right to Acquire)
2025-12-09−7,700→ 39,000 totalExercise: $59.26From: 2020-05-08Exp: 2026-05-07→ Common Stock (7,700 underlying)
Holdings
- 266,318(indirect: By Trust)
Common Stock
Footnotes (2)
- [F1]The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on July 29, 2025.
- [F2]This transaction was executed in multiple trades at prices ranging from $84.09 to $85.07. The price reported above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide, uponrequest by the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction was effected.
Documents
Issuer
Edwards Lifesciences Corp
CIK 0001099800
Entity typeother
Related Parties
1- filerCIK 0001446989
Filing Metadata
- Form type
- 4
- Filed
- Dec 8, 7:00 PM ET
- Accepted
- Dec 9, 5:01 PM ET
- Size
- 9.6 KB